Role of Transcutaneous Electric Nerve Stimulation Therapy as Adjuvant Pain Reduction in the Management of Temporomandibular Disorders

Muhammad  Hamza Asif; Saad Mahmood; Ruhma  Tariq; Hafsa Razzaq; Sana Somair; Talha  Ahmed Khan

doi:10.51253/pafmj.v76iSUPPL-10.14105

Authors

Muhammad Hamza Asif Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Saad Mahmood Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Ruhma Tariq Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Hafsa Razzaq Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Sana Somair Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Talha Ahmed Khan Department of Dental, Armed Forces Institute of Dentistry, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-10.14105

Keywords:

Orofacial Pain; Pain Management; Temporomandibular Joint Disorders; Transcutaneous Electric Nerve Stimulation.

Abstract

Objective: To evaluate and compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) therapy and conventional pharmacologic treatment in reducing pain intensity among patients with temporomandibular disorders (TMD).

Study Design: Quasi-experimental study.

Place and Duration of the Study: Department of Oral Medicine and Radiology, Armed Forces Institute of Dentistry (AFID), Rawalpindi, Pakistan from Feb to Jul 2025.

Methodology: A total of 60 patients clinically diagnosed with TMD-associated pain were enrolled and divided into two equal groups. Group-A received pharmacologic therapy consisting of a combination of diclofenac potassium (50 mg), paracetamol (325 mg), and chlorzoxazone (250 mg) three times daily for five days. Group-B received two sessions of TENS therapy, each lasting 30 minutes and five days apart, along with the same medication. Pain intensity was assessed using the Visual Analog Scale (VAS) before and after treatment.

Results: The mean pain score in Group A decreased from 5.03±0.56 to 1.10±0.48 (p<0.001), and in Group B from 5.13±0.57 to 0.97±0.56 (p<0.001). Post-treatment comparison revealed significantly greater pain reduction in the TENS group compared to the pharmacologic group (p=0.002).

Conclusion: Both treatment modalities significantly alleviated TMD-associated pain; however, TENS therapy demonstrated superior pain relief, supporting its role as an effective adjunct to conventional management.

Downloads

Download data is not yet available.

References

1. Maini K, Dua A. Temporomandibular joint syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

2. Saranya, S, Janakiram C, Mathew A. Prevalence of temporomandibular joint dysfunction among the indigenous population of India. J Oral Biol Craniofac Res 2024; 14(3): 312–316. https://doi.org/10.1016/j.jobcr.2024.04.002

3. Alqutaibi AY, Alhammadi MS, Hamadallah HH, Altarjami AA, Malosh OT, Aloufi AM, et al. Global prevalence of temporomandibular disorders: a systematic review and meta-analysis. J Oral Facial Pain Headache 2025; 39(2): 48–65.

https://doi.org/10.22514/jofph.2025.025

4. Teoli D, An J. Transcutaneous electrical nerve stimulation (TENS). StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.

5. Shi Y, Wu W. Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress. BMC Med 2023; 21(1): 372. https://doi.org/10.1186/s12916-023-03076-2

6. Indra G. Efficacy of Transcutaneous Electric Nerve Stimulation over Systemic Pharmacotherapy in the Management of Temporomandibular Joint Disorders – A Systematic Review and Meta-Analysis. J Indian Acad Oral Med Radiol 2021; 33(3): 321-327. https://doi.org/10.4103/jiaomr.jiaomr_131_21

7. Fertout A, Manière-Ezvan A, Lupi L, Ehrmann E. Management of temporomandibular disorders with transcutaneous electrical nerve stimulation: A systematic review. Cranio 2022; 40(3): 217–228. https://doi.org/10.1080/08869634.2019.1687986

8. Ferreira AP, Costa DR, Oliveira AI, Carvalho EA, Conti PC, Costa YM, et al. Short-term transcutaneous electrical nerve stimulation reduces pain and improves the masticatory muscle activity in temporomandibular disorder patients: a randomized controlled trial. J Appl Oral Sci 2017; 25(2): 112–120.

https://doi.org/10.1590/1678-77572016-0173

9. Shanavas M, Chatra L, Shenai P, Rao PK, Jagathish V, Kumar SP, et al. Transcutaneous electrical nerve stimulation therapy: an adjuvant pain-controlling modality in TMD patients—a clinical study. Dent Res J 2014; 11(6): 676–679.

10. Awan KH, Patil S. The role of transcutaneous electrical nerve stimulation in the management of temporomandibular joint disorder. J Contemp Dent Pract 2015; 16(12): 984–986.

https://doi.org/10.5005/jp-journals-10024-1792

11. Serrano-Muñoz D, Beltran-Alacreu H, Martín-Caro Á, Fernández-Pérez JJ, Aceituno-Gómez J, Arroyo-Fernández R, et al. Effectiveness of different electrical stimulation modalities for pain and masticatory function in temporomandibular disorders: a systematic review and meta-analysis. J Pain 2023; 24(6): 946–956. https://doi.org/10.1016/j.jpain.2023.01.016

12. Johnson MI, Paley CA, Jones G, Mulvey MR, Wittkopf PG. Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis. BMJ Open 2022; 12(2): e051073. https://doi.org/10.1136/bmjopen-2021-051073

13. Vance CGT, Dailey DL, Chimenti RL, Van Gorp BJ, Crofford LJ, Sluka KA. Using TENS for Pain Control: Update on the State of the Evidence. Medicina 2022; 58(10): 1332.

https://doi.org/10.3390/medicina58101332

14. Alam M, Tabrizi R, Mohammadikhah M, Farzan A, Moslemi H, Farzan A, et al. Effect of transcutaneous electrical nerve stimulation on maximum mouth opening after orthognathic surgery: a randomized controlled trial. Ann Med Surg 2024; 86(11): 6555–6560.

https://doi.org/10.1097/MS9.0000000000002597

15. Díaz L, Restelli L, Valencia E, Atalay DI, Abarca JM, Gil AC, et al. Effectiveness of low-level laser therapy on temporomandibular disorders: a systematic review of randomized clinical trials. Photodiagnosis Photodyn Ther 2025; 104558. https://doi.org/10.1016/j.pdpdt.2025.104558

16. Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S. Comparison of transcutaneous electric nerve stimulation (TENS) and microcurrent nerve stimulation (MENS) in the management of masticatory muscle pain. Pain Res Manag 2019; 2019: 8291624.

https://doi.org/10.1155/2019/8291624

17. Rehman B, Rehman MU, Din QU. The efficacy of transcutaneous electrical nerve stimulation in TMJ pain: a non-pharmacological remedy for immediate pain relief. J Khyber Coll Dent 2013; 3(2): 20–23. https://doi.org/10.33279/jkcd.v3i2.480

18. Woolf CJ. Pain modulation in the spinal cord. Front Pain Res 2022; 3: 984042. https://doi.org/10.3389/fpain.2022.984042

19. Patel P, Green M, Tram J, Wang E, Murphy M, Abd-Elsayed AA, et al. Latest advancements in transcutaneous electrical nerve stimulation (TENS) and electronic muscle stimulation (EMS): revisiting an established therapy with new possibilities. J Pain Res 2025; 18: 137–153. https://doi.org/10.2147/JPR.S493162

20. Szyszka-Sommerfeld L, Machoy M, Lipski M, Woźniak K. Electromyography as a means of assessing masticatory muscle activity in patients with pain-related temporomandibular disorders. Pain Res Manag 2020; 2020: 9750915.

https://doi.org/10.1155/2020/9750915

21. Rodrigues D, Siriani AO, Bérzin F. Effect of conventional TENS on pain and electromyographic activity of masticatory muscles in TMD patients. Braz Oral Res 2004; 18(4): 290–295.

https://doi.org/10.1590/S1806-83242004000400003